Clinical Trial Update: TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating total marrow irradiation with high-dose melphalan as conditioning for autologous stem cell transplantation in relapsed/refractory multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Alkeran) (melphalan)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment | Phase 1 | Status: COMPLETED | Results posted: 2024-10-21